JUN 18, 2018 6:25 AM PDT

Detecting and Diagnosing Rheumatoid Arthritis Before it Begins

WRITTEN BY: Kara Marker

Unique gene signatures and tiny changes in the immune system that occur in the earliest stages of rheumatoid arthritis, an autoimmune disease, could soon be used to apply new diagnostic methods and provide early therapeutic intervention. From the European League Against Rheumatism (EULAR), scientists present their newest findings on how to identify which at-risk individuals will ultimately develop rheumatoid arthritis.

Rheumatoid arthritis: X-ray image of the hand with large changes in destructive arthritis.

People with rheumatoid arthritis (RA) are plagued with chronic inflammation in the joints, often the hands, feet, wrists, elbows, knees, and ankles. Inflammation in the joints causes the synovium to thicken, the joint tissue responsible for lubricating the joints and allowing easy movement. This thickening is what leads to the swelling and pain experienced by RA patients. Findings from this study could one day lead to early therapeutic interventions that could prevent irreversible damage to the joints and inhibit progression of the disease.

When specific autoantibodies are discovered, a person is known to be an increased risk of developing RA, although the presence of these autoantibodies does not necessarily seal their fate. Autoantibodies are produced in many different autoimmune diseases. They represent a malfunction in the immune system, where B cells produce antibodies that target the body’s own cells and tissues instead of producing antibodies that target foreign invaders like bacteria and viruses.

"These studies may help us better understand and potentially identify which individuals classified as at-risk will go on to develop RA," explained EULAR’s Robert Landewé. "This is important because it will contribute to the development of early preventative strategies including potential pharmacological treatment to prevent the onset of disease."

Researchers began their study with 67 synovial tissue samples from the knee joint of individuals with an early risk of RA. With just 13 participants, they conducted a genome-wide transcriptional profile study aimed at identifying unique gene signatures associated with RA development. They found 3,151 gene signatures linked to elevated risk of RA and 2,437 signatures linked with a lower risk. They confirmed these results using a technique called quantitative real-time PCR.

"Our results clearly show molecular changes appearing in the synovial tissue before the onset of arthritis," said Dr. Lisa van Baarsen. "The characterization of these gene signatures will enable us to better understand the pathophysiology of the pre-clinical phase of the disease and potentially identify novel drug targets for preventive intervention."

In addition to classifying genetic risk biomarkers, researchers also observed changes in immune-regulated pathways involving T cells and B cells, cytokines and chemokines, and antigen processing and presentation.

"Our data support a new biomarker that demonstrates better predictive power compared with other available biomarkers evaluated so far," said Ms. Anne Musters, MD.

The findings from this study were recently presented at the Annual European Congress of Rheumatology.

Sources: Arthritis Foundation, European League Against Rheumatism (EULAR)

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JAN 26, 2021
Immunology
COVID Vaccine Reactions: You're As Likely to Be Struck by Lightning
JAN 26, 2021
COVID Vaccine Reactions: You're As Likely to Be Struck by Lightning
In a period of just over three weeks, over four million people received Moderna’s COVID-19 vaccine. Out of all the ...
JAN 27, 2021
Drug Discovery & Development
Do Vaccines Work Against New Covid Variants?
JAN 27, 2021
Do Vaccines Work Against New Covid Variants?
The SARS-CoV-2 virus is mutating faster than scientists previously thought. As such, pharmaceutical companies are now sc ...
FEB 10, 2021
Drug Discovery & Development
Black Men Respond Best to Immunotherapy for Prostate Cancer
FEB 10, 2021
Black Men Respond Best to Immunotherapy for Prostate Cancer
Researchers from Northwestern University have found that Black men and men of African ancestry respond better than men f ...
MAR 18, 2021
Immunology
"Brainwashed" Immune Cells Help Breast Tumors Thrive
MAR 18, 2021
"Brainwashed" Immune Cells Help Breast Tumors Thrive
Immunologists have discovered a mechanism through which immune cells get recruited into breast cancer tumors, and instea ...
APR 19, 2021
Cell & Molecular Biology
Insight Into the Molecular Basis of Rheumatoid Arthritis
APR 19, 2021
Insight Into the Molecular Basis of Rheumatoid Arthritis
New research has shown how variants in an immune gene can lead to a high risk of developing the autoimmune disorder rheu ...
MAY 19, 2021
Health & Medicine
Who Ages Better, Men or Women?
MAY 19, 2021
Who Ages Better, Men or Women?
The answer depends on what's considered more important – quantity or quality of years?  Previous studies ...
Loading Comments...